| Clinical and biomarker changes in dominantly inherited Alzheimer's disease RJ Bateman, C Xiong, TLS Benzinger, AM Fagan, A Goate, NC Fox, ... New England Journal of Medicine 367 (9), 795-804, 2012 | 4762 | 2012 |
| Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ... The Lancet Neurology 12 (4), 357-367, 2013 | 2700 | 2013 |
| High performance plasma amyloid-β biomarkers for Alzheimer’s disease A Nakamura, N Kaneko, VL Villemagne, T Kato, J Doecke, V Doré, ... Nature 554 (7691), 249-254, 2018 | 1910 | 2018 |
| Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. CL Masters, G Multhaup, G Simms, J Pottgiesser, RN Martins, ... The EMBO journal 4 (11), 2757-2763, 1985 | 1381 | 1985 |
| Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ... Neurobiology of aging 31 (8), 1275-1283, 2010 | 1197 | 2010 |
| Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ... Annals of neurology 69 (1), 181-192, 2011 | 1093 | 2011 |
| The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of … KA Ellis, AI Bush, D Darby, D De Fazio, J Foster, P Hudson, ... International psychogeriatrics 21 (4), 672-687, 2009 | 1086 | 2009 |
| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 992 | 2019 |
| Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease B Rumble, R Retallack, C Hilbich, G Simms, G Multhaup, R Martins, ... New England Journal of Medicine 320 (22), 1446-1452, 1989 | 859 | 1989 |
| A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nature medicine 26 (3), 398-407, 2020 | 672 | 2020 |
| Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis DC Ryman, N Acosta-Baena, PS Aisen, T Bird, A Danek, NC Fox, A Goate, ... Neurology 83 (3), 253-260, 2014 | 635 | 2014 |
| White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network S Lee, F Viqar, ME Zimmerman, A Narkhede, G Tosto, TLS Benzinger, ... Annals of neurology 79 (6), 929-939, 2016 | 617 | 2016 |
| Regular care and maintenance of a zebrafish (Danio rerio) laboratory: an introduction A Avdesh, M Chen, MT Martin-Iverson, A Mondal, D Ong, S Rainey-Smith, ... Journal of Visualized Experiments (JoVE), e4196, 2012 | 581 | 2012 |
| Alzheimer's β-amyloid peptides compete for insulin binding to the insulin receptor L Xie, E Helmerhorst, K Taddei, B Plewright, W Van Bronswijk, R Martins The Journal of Neuroscience 22 (10), RC221, 2002 | 576 | 2002 |
| World‐Wide FINGERS Network: a global approach to risk reduction and prevention of dementia M Kivipelto, F Mangialasche, HM Snyder, R Allegri, S Andrieu, H Arai, ... Alzheimer's & dementia 16 (7), 1078-1094, 2020 | 575 | 2020 |
| Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need GM Babulal, YT Quiroz, BC Albensi, E Arenaza-Urquijo, AJ Astell, ... Alzheimer's & Dementia 15 (2), 292-312, 2019 | 547 | 2019 |
| Increased risk of cognitive impairment in patients with diabetes is associated with metformin EM Moore, AG Mander, D Ames, MA Kotowicz, RP Carne, H Brodaty, ... Diabetes care 36 (10), 2981-2987, 2013 | 528 | 2013 |
| Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease IJ Martins, E Hone, JK Foster, SI Sünram-Lea, A Gnjec, SJ Fuller, D Nolan, ... Molecular psychiatry 11 (8), 721-736, 2006 | 524 | 2006 |
| Blood-based protein biomarkers for diagnosis of Alzheimer disease JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ... Archives of neurology 69 (10), 1318-1325, 2012 | 518 | 2012 |
| A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic … L Davies, B Wolska, C Hilbich, G Multhaup, R Martins, G Simms, ... Neurology 38 (11), 1688-1688, 1988 | 508 | 1988 |
